Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
11/11/2014 | US8883214 Implantable delivery vehicle for ocular delivery of muscarinic antagonists |
11/11/2014 | US8883213 Ion exchange resin treated to control swelling |
11/11/2014 | US8883211 Polyoxazolines with inert terminating groups, polyoxazolines prepared from protected initiating groups and related compounds |
11/11/2014 | US8883210 Tissue-derived tissuegenic implants, and methods of fabricating and using same |
11/11/2014 | US8883209 Pharmaceutical solid dispersions |
11/11/2014 | US8883208 Particles for delivery of nucleic acids and related devices and methods |
11/11/2014 | US8883207 Controlled release carvedilol formulation |
11/11/2014 | US8883206 Pharmaceutical composition and administrations thereof |
11/11/2014 | US8883205 Microtablet-based pharmaceutical preparation |
11/11/2014 | US8883204 Tamper resistant co-extruded dosage form containing an active agent and an adverse agent and process of making same |
11/11/2014 | US8883203 Solid oral dosage form containing an enhancer |
11/11/2014 | US8883202 Lipid compositions |
11/11/2014 | US8883201 Solid oral dosage form containing an enhancer |
11/11/2014 | US8883200 Delivery of nucleic acid-like compounds |
11/11/2014 | US8883199 Administration regime for N-hydroxy-4-{2-[3-(N,N-dimethylaminomethyl)benzofuran-2- ylcarbonylamino]ethoxy}benzamide |
11/11/2014 | US8883198 Transdermal rivastigmine therapeutic system |
11/11/2014 | US8883197 Transdermal, therapeutic system with activatable oversaturation and controlled permeation promotion |
11/11/2014 | US8883196 Transdermal hormone delivery system: compositions and methods |
11/11/2014 | US8883193 Cellulosic biocomposites as molecular scaffolds for nano-architectures |
11/11/2014 | US8883191 Method for producing individually dosed active substance-containing and, in particular, aromatics-containing film-shaped administration forms rapidly disintegrating upon contact with liquid |
11/11/2014 | US8883190 Urologic devices incorporating collagen inhibitors |
11/11/2014 | US8883189 Intraocular encapsulation of oxygenic bacteria |
11/11/2014 | US8883187 Stabilized compositions containing alkaline labile drugs |
11/11/2014 | US8883185 Hydrogel implants with varying degrees of crosslinking |
11/11/2014 | US8883177 Pharmaceutical compositions for parenteral administration |
11/11/2014 | US8883176 Smooth, high solids tablet coating composition |
11/11/2014 | US8883148 Prevention of joint destruction |
11/11/2014 | US8883146 Protein formulations and methods of making same |
11/11/2014 | US8883122 Nanoparticle clusters formed from individual nanoparticles of two or more types |
11/11/2014 | US8883121 Oral preparation useful in measurement capacity to metabolize pyridine |
11/11/2014 | US8883010 Polymer composition with phytochemical and dialysis membrane formed from the polymer composition |
11/11/2014 | US8882748 Transmucosal drug delivery device and method including chemical permeation enhancers |
11/11/2014 | US8882747 Substance delivery system |
11/11/2014 | US8882729 Transdermal therapeutic system having stabilized membrane |
11/11/2014 | US8882703 Drug delivery in association with medical or surgical procedures |
11/11/2014 | US8881894 Multiple-compartment applicator |
11/06/2014 | US20140330246 Intrauterine fetal growth restriction - The biochemical rationale of treatment modalities including extraperitoneal transamniotic fetal supplements |
11/06/2014 | US20140330244 Implantable Device for Manipulating Immune Cells |
11/06/2014 | US20140330226 Combination sis and vacuum bandage and method |
11/06/2014 | US20140330223 Transdermal therapeutic system for administering fentanyl or an analogue thereof |
11/06/2014 | US20140329913 Nanoparticles with enhanced mucosal penetration or decreased inflammation |
11/06/2014 | US20140329906 Thermogelling anaesthetic compositions |
11/06/2014 | US20140329896 Compositions and methods of treatment with proanthocyanidin polymer antidiarrheal compositions |
11/06/2014 | US20140329885 Lipids, lipid complexes and use thereof |
11/06/2014 | US20140329859 Ionic silicone hydrogels comprising pharmaceutical and/or neuticeutical components and having improved hydrolytic stability |
11/06/2014 | US20140329835 Dosage form for insertion into the mouth |
11/06/2014 | US20140329810 Aerosol fluoroquinolone formulations for improved pharmacokinetics |
11/06/2014 | US20140329788 Testosterone gel and method of use |
11/06/2014 | US20140329785 Conveniently Injectable or Implantable Sustained-Release Antioxidant Formulations for Therapies of Ocular Maladies or Cancer |
11/06/2014 | US20140329783 Transdermal hormone replacement therapies |
11/06/2014 | US20140329780 Inhibitor of colonisation of mucosa |
11/06/2014 | US20140329779 Clear solid sticks with solubilized pharmaceutical agents |
11/06/2014 | US20140329774 Injectable composition containing phosphatidylcholine devoid of sodium deoxycholate and preparing method thereof |
11/06/2014 | US20140329773 Compositions for Oral Administration of Zoledronic Acid or Related Compounds for Treating Disease |
11/06/2014 | US20140329766 Prophylactic Compositions for Management of Microbial Infections in Patients with Brain Injury |
11/06/2014 | US20140328973 Method of releasing nicotine from chewing gum |
11/06/2014 | US20140328953 Skin preparation composition for external use having excellent antiseptic ability |
11/06/2014 | US20140328939 Method for preparing biocompatible small intestinal mucosa hydrogel capable of controlling in-vivo degradation period |
11/06/2014 | US20140328937 Drug Delivery Systems and Use Thereof |
11/06/2014 | US20140328934 Granules for pharmaceutical preparations, methods and apparatus for their production |
11/06/2014 | US20140328933 Novel formulations and methods |
11/06/2014 | US20140328931 Nucleic acid particles, methods and use thereof |
11/06/2014 | US20140328930 Pharmaceutical Compositions |
11/06/2014 | US20140328926 Modified hyaluronic acid polymer compositions and related methods |
11/06/2014 | US20140328925 Micronized tanaproget, compositions, and methods of preparing the same |
11/06/2014 | US20140328924 Delivery of immunosuppressants having a specified pharmacodynamic effective-life and antigen for the induction of immune tolerance |
11/06/2014 | US20140328920 System for the delivery of biologically active compounds into an organism and method for the preparation of said system |
11/06/2014 | US20140328917 Organic compound nano-powder, method for producing the same and suspension |
11/06/2014 | US20140328915 Dosage form for insertion into the mouth |
11/06/2014 | US20140328914 Talc-free polyvinyl alcohol composition |
11/06/2014 | US20140328913 Rapidly disintegrating gelatinous coated tablets |
11/06/2014 | US20140328912 Delayed Release Tablet With Defined Core Geometry |
11/06/2014 | US20140328910 Ingestion method of creatine composition, creatine composition for using in the ingestion method, and creatine-containing medicament and food each produced using the creatine composition |
11/06/2014 | US20140328908 Controlled-release formulation |
11/06/2014 | US20140328907 Entrapment of bioactives in sol-gel alumina materials |
11/06/2014 | US20140328905 Methods and compositions for x-ray induced release from ph sensitive liposomes |
11/06/2014 | US20140328901 Methods for using interferon gamma to absorb fluid from the subretinal space |
11/06/2014 | US20140328899 Liposomes co-encapsulating a bisphosphonate and an amphipathic agent |
11/06/2014 | US20140328898 Nano-Liposomal Formulations and Methods of Use |
11/06/2014 | US20140328885 Sheet for cutaneous application containing vitamin e or an ester thereof |
11/06/2014 | US20140328878 Malleable protein matrix and uses thereof |
11/06/2014 | US20140328835 Methods for treating retinopathy with extended therapeutic effect |
11/06/2014 | US20140328816 Packaged probiotic composition and uses thereof |
11/06/2014 | US20140328770 Topical tetracycline compositions |
11/06/2014 | US20140328769 High Oil-Content Emollient Aerosol Foam Compositions |
11/06/2014 | US20140328763 Bioactive amphiphilic polymer stabilized nanoparticles with enhanced stability and activity |
11/06/2014 | US20140328759 Limit size lipid nanoparticles and related methods |
11/06/2014 | US20140326759 Medicinal aerosols and methods of delivery thereof |
11/04/2014 | US8877902 Formulations and methods for weight loss and body contouring |
11/04/2014 | US8877814 Titration package for neramexane and its use in the treatment of an inner ear disorder |
11/04/2014 | US8877813 Antiinflammatory and analgesic preparation for external use |
11/04/2014 | US8877807 Compositions and methods for reducing body fat |
11/04/2014 | US8877792 Compositions for increasing solubility of azole drug compounds that are poorly soluble in water |
11/04/2014 | US8877790 Allantoin-containing skin cream |
11/04/2014 | US8877789 Allantoin-containing skin cream |
11/04/2014 | US8877788 Allantoin-containing skin cream |
11/04/2014 | US8877774 Compounds having muscarinic receptor antagonist and beta2 Adrenergic receptor agonist activity |
11/04/2014 | US8877768 Method and composition for treating alzheimer-type dementia |
11/04/2014 | US8877740 Compound composition for inhalation used for treating asthma |
11/04/2014 | US8877732 Combination, kit and method of reducing intraocular pressure |